BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7802237)

  • 1. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
    Maddineni VR; Mirakhur RK; McCoy EP
    Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases.
    McCoy EP; Mirakhur RK; Maddineni VR; Loan PB; Connolly F
    Anaesthesia; 1994 Nov; 49(11):940-5. PubMed ID: 7802236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery.
    Connolly FM; Mirakhur RK; Loan PB; McCoy EP; Symington M; Kumar N
    Br J Anaesth; 1995 Feb; 74(2):229-30. PubMed ID: 7696074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
    Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR
    Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block.
    Abdulatif M
    Br J Anaesth; 1995 Jan; 74(1):20-5. PubMed ID: 7880699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.
    Ting CK; Lin SM; Yang YW; Tsai HJ; Lao HC; Chu YC; Tsai SK
    Acta Anaesthesiol Sin; 2001 Dec; 39(4):157-62. PubMed ID: 11840581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
    Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antagonism of mivacurium-induced neuromuscular block on postoperative emesis in children.
    Watcha MF; Safavi FZ; McCulloch DA; Tan TS; White PF
    Anesth Analg; 1995 Apr; 80(4):713-7. PubMed ID: 7893023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.